These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24959941)

  • 1. Development of a high-throughput assay for aldosterone synthase inhibitors using high-performance liquid chromatography-tandem mass spectrometry.
    Yurek D; Yu L; Schrementi J; Bell MG; McGee J; Kowala M; Kuo MS; Wang J
    Anal Biochem; 2014 Oct; 462():44-50. PubMed ID: 24959941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of a whole-cell based medium throughput screening system for the discovery of human aldosterone synthase (CYP11B2) inhibitors: old drugs disclose new applications for the therapy of congestive heart failure, myocardial fibrosis and hypertension.
    Hakki T; Hübel K; Waldmann H; Bernhardt R
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):120-8. PubMed ID: 21193036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYP11B1 (steroid-11beta-hydroxylase) inhibitors.
    Müller-Vieira U; Angotti M; Hartmann RW
    J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):259-70. PubMed ID: 15985365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors.
    LaSala D; Shibanaka Y; Jeng AY
    Anal Biochem; 2009 Nov; 394(1):56-61. PubMed ID: 19622340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The establishment of a novel high-throughput screening system using RNA-guided genome editing to identify chemicals that suppress aldosterone synthase expression.
    Ito R; Morita M; Nakano T; Sato I; Yokoyama A; Sugawara A
    Biochem Biophys Res Commun; 2021 Jan; 534():672-679. PubMed ID: 33220920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivo.
    Ries C; Lucas S; Heim R; Birk B; Hartmann RW
    J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):121-6. PubMed ID: 19427380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a test system for inhibitors of human aldosterone synthase (CYP11B2): screening in fission yeast and evaluation of selectivity in V79 cells.
    Ehmer PB; Bureik M; Bernhardt R; Müller U; Hartmann RW
    J Steroid Biochem Mol Biol; 2002 Jun; 81(2):173-9. PubMed ID: 12137808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Aldosterone Synthase Inhibitor FAD286 is Suitable for Lowering Aldosterone Levels in ZDF Rats but not in db/db Mice.
    Hofmann A; Brunssen C; Peitzsch M; Balyura M; Mittag J; Frenzel A; Jannasch A; Brown NF; Weldon SM; Gueneva-Boucheva KK; Eisenhofer G; Bornstein SR; Morawietz H
    Horm Metab Res; 2017 Jun; 49(6):466-471. PubMed ID: 28427090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel aldosterone synthase inhibitor ameliorates mortality in pressure-overload mice with heart failure.
    Furuzono S; Meguro M; Miyauchi S; Inoue S; Homma T; Yamada K; Tagawa YI; Nara F; Nagayama T
    Eur J Pharmacol; 2017 Jan; 795():58-65. PubMed ID: 27915044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.
    Qin CZ; Ren X; Tan ZR; Chen Y; Yin JY; Yu J; Qu J; Zhou HH; Liu ZQ
    Biomed Chromatogr; 2014 Feb; 28(2):197-203. PubMed ID: 23946123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a solid phase extraction method for the simultaneous determination of steroid hormones in H295R cell line using liquid chromatography-tandem mass spectrometry.
    Abdel-Khalik J; Björklund E; Hansen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Sep; 935():61-9. PubMed ID: 23948237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput mass spectrometric cytochrome P450 inhibition screening.
    Lim KB; Ozbal CC; Kassel DB
    Methods Mol Biol; 2013; 987():25-50. PubMed ID: 23475665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry.
    Hinchliffe E; Carter S; Owen LJ; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 913-914():19-23. PubMed ID: 23266360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone synthase inhibitors for cardiovascular diseases: A comprehensive review of preclinical, clinical and in silico data.
    Lenzini L; Zanotti G; Bonchio M; Rossi GP
    Pharmacol Res; 2021 Jan; 163():105332. PubMed ID: 33271294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
    Dasgupta M; Tang W; Caldwell GW; Yan Z
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput determination of cortisol, cortisone, and melatonin in oral fluid by on-line turbulent flow liquid chromatography interfaced with liquid chromatography/tandem mass spectrometry.
    Fustinoni S; Polledri E; Mercadante R
    Rapid Commun Mass Spectrom; 2013 Jul; 27(13):1450-60. PubMed ID: 23722679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a rapid and integrated analysis system (RIAS) as a high-throughput processing tool for in vitro ADME samples by liquid chromatography/tandem mass spectrometry.
    Luippold AH; Arnhold T; Jörg W; Krüger B; Süssmuth RD
    J Biomol Screen; 2011 Mar; 16(3):370-7. PubMed ID: 21335598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of multiplexed, multi-dimensional ultra-high-performance liquid chromatography/tandem mass spectrometry to the high-throughput screening of lysosomal storage disorders in newborn dried bloodspots.
    Kasper DC; Herman J; De Jesus VR; Mechtler TP; Metz TF; Shushan B
    Rapid Commun Mass Spectrom; 2010 Apr; 24(7):986-94. PubMed ID: 20209662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
    Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
    J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.